Direct Flow's TAVI system gets EU thumbs up

Editorial Staff | | Cardiovascular Business | Structural Heart Disease

Direct Flow Medical has received CE Mark for its transcatheter aortic heart valve with a metal-free frame and low-profile transfemoral delivery system. The design also creates a seal around the annulus.

Two sizes of valves—25mm and 27mm—will be commercially available in Europe immediately, both delivered via an 18 French system.

To support European commercialization, the Santa Rosa, Calif.-based company also appointed Dan Rose as vice president of sales and marketing. Most recently, Rose was vice president of commercial operations for Sequana Medical, an Swiss medical device company developing implantable pump systems. Prior to that, Rose held a number of sales and marketing leadership positions at Medtronic in Europe in both the interventional cardiology and cardiac surgery businesses.

Editorial Staff

Related Content

CMS proposes Medicare coverage for transcatheter tricuspid valve replacement
Hydra TAVR valve gains key approval as global reach continues to grow
SAVR outperforms TAVR in patients with bicuspid aortic valves
Treating AFib patients with TAVR still linked to elevated risks
Heart surgeons detail world’s first robotic heart procedure of its kind
Years of progress have made TAVR more effective when treating concomitant mitral stenosis

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.